Polydeoxyribonucleotide Promotes Longitudinal Bone Growth Through the Hepatic JAK2-STAT5/IGF-1 Axis Involving A2A Receptor Signaling
Molecules · 2026
DOI: 10.3390/molecules31193558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Kyung-Min Jeong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio-Convergence System, Hoseo University, 20 Hoseo-ro, 79 Beon-gil, Baebang-eup, Asan 31499, Chungcheongnam-do, Republic of Korea. Hauptthemen laut MEDLINE: Janus Kinase 2, Insulin-Like Growth Factor I, STAT5 Transcription Factor, Signal Transduction. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Longitudinal bone growth is primarily regulated by the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis. However, non-hormonal and orally administered strategies for promoting longitudinal growth remain limited. Here, we investigated the effects and mechanisms of polydeoxyribonucleotide (PDRN) on longitudinal bone growth in vitro and in vivo. In HepG2 cells, PDRN significantly increased IGF-1 mRNA expression and JAK2 and STAT5 phosphorylation without affecting cell viability. Pretreatment with ZM241385, a selective adenosine A2A receptor (A2AR) antagonist, significantly attenuated these responses, supporting the involvement of A2AR signaling. In mice, oral PDRN for 5 weeks significantly increased body length gain, growth plate thickness, and hepatic JAK2/STAT5 activation, elevating serum IGF-1 levels without altering GH levels or systemic toxicity markers. Quantitative micro-computed tomography analysis demonstrated improved trabecular and cortical bone microarchitecture with reduced porosity. Furthermore, PDRN modulated bone remodeling-related responses by suppressing lipopolysaccharide-induced osteoclastogenic marker expression in RAW 264.7 cells and enhancing osteogenic marker expression while downregulating RANKL in MC3T3-E1 cells. Overall, oral PDRN promotes longitudinal bone growth and improves microarchitecture via increased hepatic IGF-1 signaling and altered bone remodeling-related gene expression, supporting its potential as an oral candidate for skeletal growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bio-Convergence System, Hoseo University, 20 Hoseo-ro, 79 Beon-gil, Baebang-eup, Asan 31499, Chungcheongnam-do, Republic of Korea.
- Department of Food and Biotechnology, Graduate School, Hoseo University, Baebang-eup, Asan 31499, Chungcheongnam-do, Republic of Korea.
- COSMAX NBT INC., Seongnam-si 13486, Gyeonggi-do, Republic of Korea.
- Department of Biochemistry and Molecular Biology, Jeonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju-si 54907, Jeollabuk-do, Republic of Korea.
ORCID-Profile: So-Young Rah, Hyun-Ja Jeong
Zitieren
APA
Jeong, K. M., Choi, Y. J., Yang, S. B., Kweon, M., Rah, S. Y., & Jeong, H. J. (2026). Polydeoxyribonucleotide Promotes Longitudinal Bone Growth Through the Hepatic JAK2-STAT5/IGF-1 Axis Involving A2A Receptor Signaling. Molecules. https://doi.org/10.3390/molecules31193558
Vancouver
Jeong KM, Choi YJ, Yang SB, Kweon M, Rah SY, Jeong HJ. Polydeoxyribonucleotide Promotes Longitudinal Bone Growth Through the Hepatic JAK2-STAT5/IGF-1 Axis Involving A2A Receptor Signaling. Molecules. 2026. doi:10.3390/molecules31193558
BibTeX
@article{Jeong2026,
author = {Jeong, Kyung-Min and Choi, Yu-Jin and Yang, Seong-Been and Kweon, Minson and Rah, So-Young and Jeong, Hyun-Ja},
title = {Polydeoxyribonucleotide Promotes Longitudinal Bone Growth Through the Hepatic JAK2-STAT5/IGF-1 Axis Involving A2A Receptor Signaling},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31193558}
}
EUVIMED